Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting

 July 30, 2007

 

SLIDES

 

Guest Speaker Presentation

 

Robert E. Ratner, M.D., (ppt) (html)

Vice-President of Scientific Affairs, MedStar Research Institute

           

GlaxoSmithKline Presentation

 

Ronald L. Krall, M.D., GlaxoSmithKline (pdf)

 

Murray W. Stewart, D.M., F.R.C.P., GlaxoSmithKline (pdf)

 

Ronald L. Krall, M.D., GlaxoSmithKline (pdf)

 

FDA Presentations

 

Joy D. Mele, M.S. (ppt) (html)

 

Karen M. Mahoney, M.D. (ppt) (html)

 

Kate Gelperin, M.D., M.P.H. (ppt) (html)

 

David Graham, M.D., M.P.H. (ppt) (html)

 

NIH Speaker Presentation

 

David J. Gordon, M.D., Ph.D. (ppt) (html)

 

Open Public Hearing

 

George A. Diamond, M.D., F.A.C.C. and Sanjay Kaul, M.D., F.A.C.C., (ppt) (html)

Cedar-Sinai Medical Center

 

David Egilman, M.D., Brown University (ppt) (html)

 

Richard Hellman, M.D., F.A.C.P., F.A.C.E., President, American Association of Clinical Endocrinologists (ppt) (html)

 

Sidney Wolfe, M.D., Public Citizen’s Health Research Group (ppt) (html)

 

Michael R. Peterson, D.V.M, M.P.H., Dr.PH. and Thomas Bacon, Pharm.D, Office of Assistant Secretary of Defense for Health Affairs/TRICARE (ppt) (html)

 

 

Samuel Nussbaum, M.D., Executive Vice-President and CMO, Wellpoint Inc (ppt) (html)

 

  J. Rick Turner, Ph.D., P.G.C.E. Chairman, Department of Clinical Research, Campbell University School of Pharmacy, RTP Campus (ppt) (html)

 

Richard E. Ralston, Executive Director, Americans for Free Choice in Medicine (pdf)

---

Up | AC Home Page